gadolinium has been researched along with Prostatic Neoplasms in 86 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 13 (15.12) | 18.2507 |
2000's | 17 (19.77) | 29.6817 |
2010's | 49 (56.98) | 24.3611 |
2020's | 7 (8.14) | 2.80 |
Authors | Studies |
---|---|
Chirayil, S; Clavijo Jordan, MV; Dao, E; Farquharson, MJ; Geraki, K; Martins, AF; Sherry, AD | 1 |
Aydin, H; Ayyildiz, VA; Karaibrahimoglu, A; Topsakal, K | 1 |
Abdullahi, IN; Abramikas, Z; Agliani, G; Ahangar, N; Ahmed, AR; Aidietis, A; Aiying, W; Alabi, A; Álvarez, K; Anderson, L; André, MR; Araújo-Júnior, JX; Arqué, E; Asakereh, A; Audzijoniene, D; Azer, MK; Bacevicius, J; Badaras, I; Bagaev, A; Bailly, C; Bakky, MAH; Baojun, Y; Baran, E; Barbosa, RFS; Barzon, L; Basit, A; Basler, E; Bassi, ÊJ; Basyte-Bacevice, V; Bielak, K; Bileisiene, N; Birczyński, A; Blom, R; Boesen, L; Boucoiran, I; Bouwknegt, M; Brandão, JA; Bravo, F; Brien, MÈ; Bruijning-Verhagen, PCJL; Butkuviene, M; Cai, DC; Cai, X; Camani, PH; Cao, S; Carey, IM; Chakravarthy, C; Chandler, F; Chang, SW; Chen, C; Chen, H; Chen, J; Chen, S; Chen, T; Chen, W; Chen, X; Chen, Y; Chen, YT; Chen, Z; Chou, WC; Choudhary, S; Chu, W; Chung, H; Cilin, W; Coelho, GL; Collet, C; Cools, C; Cooper, A; Corkhill, CL; Cornelis, JT; Costa, CACB; Currie, A; da S Ferreira, G; da Silva, DJ; Dai, Y; Dal Soglio, D; de Bellegarde de Saint Lary, C; de Bruin, E; de Los Ríos, JD; Deenadayalan, B; Del Río, M; Ding, HT; Dong, GH; Dong, K; Dorożyński, P; Drössler, L; Dvinelis, E; Ebrahimi, M; Fan, W; Fan, Z; Feng, Y; Ferreira, RR; Fortunov, RM; Freitas, JD; Gan, J; Gao, J; García-Depraect, O; Ge, Q; Giglia, G; Giguère, F; Girard, S; Godfrey, J; Gokyar, S; Gonçalves, LR; Gong, S; Gouder, T; Graf, C; Grinter, S; Gröne, A; Gudauskas, M; Guo, T; Guo, Y; Guryanova, OA; Hagan, JL; Hamamoto, K; Hansen, AE; Hasnan, NSN; He, X; He, YL; Hessel, V; Heym, M; Hindle, S; Hogan, CA; Hogema, BM; Hu, J; Hu, P; Huang, M; Huang, S; Huang, X; Huang, Y; Hyatt, NC; Jacobson, C; Jakaite, R; Jasiunas, E; Jeffres, MN; Ji, CF; Jia, K; Jia, Z; Jian, T; Jiang, L; Jiang, W; Jiang, X; Jiang, Y; Jiang, Z; Jiao, Y; Jin, JH; Jing, T; Johnson, L; Ju, L; Jukna, E; Juknevicius, V; Jung, J; Kakkar, F; Kalpana, ML; Kamankesh, M; Kan, E; Kan, N; Karuzas, A; Kasbergen, LMR; Kassim, MB; Ke, Z; Kettles, K; Khan, OA; Khattab, M; Khoee, S; Kiel, E; Kik, M; Kiseliute, M; Kline, JP; Koonce, RC; Koopmans, MPG; Korboulewsky, N; Krause, A; Kulinowski, P; Kundelis, R; La, DD; Lai, HT; Lai, Q; Lange, U; Lasheen, ESR; Latorre-Fernandez, J; Lei, M; Lesperance, J; Li, DC; Li, H; Li, HY; Li, JF; Li, K; Li, L; Li, M; Li, N; Li, P; Li, Q; Li, S; Li, T; Li, WN; Li, X; Li, Y; Li, Z; Liang, C; Liang, H; Liang, M; Liao, H; Liao, Y; Liu, C; Liu, H; Liu, K; Liu, X; Liu, XQ; Liu, Y; Löf, M; Long, Z; Lozano, C; Lu, X; Lühken, R; Luo, H; Lv, T; Lyu, CY; Lyu, T; Løgager, V; Ma, C; Ma, H; Ma, SJ; Machado, RZ; Mafakheri, F; Mahawar, K; Maheshkumar, K; Manga, P; Mao, XR; Marciano, JS; Marinskiene, J; Marozas, V; McGlone, ER; Meester, M; Mella, A; Meng, X; Meng, Z; Meulenbroek, CB; Min, QQ; Mohamed, MA; Molina, D; Monti, G; Mortimer, RJG; Mottram, LM; Mpanya, D; Müller, A; Muñoz, R; Muys, B; Myczko, Ł; Møller, JM; Najib, Y; Navarro, M; Nel, S; Neveln, NK; Nguyen, DD; Nguyen, PHT; Ni, S; Niu, Y; Nomie, K; Nordin, NA; Norvell, MR; Nothdurft, A; Okui, MA; Okui, N; Osei, R; Osorio-Tejada, JL; Ouyang, D; Pach, M; Pan, B; Pan, G; Paredes, R; Párraga-Niño, N; Passos, GFS; Patil, RS; Pedro-Botet, ML; Pelletier, F; Petrylaite, M; Pham, KTT; Pilkiene, A; Ponette, Q; Popov, Y; Porter, M; Postovalova, E; Pretzsch, H; Pring, C; Pu, M; Puigoriol, E; Qi, B; Qi, H; Qi, Y; Qiao, T; Qin, S; Qiu, Y; Qiu, Z; Quero, S; Ramsay, M; Rao, J; Rashwan, MA; Rathod, DK; Rebrov, E; Regueira-Marcos, L; Ren, Y; Reynaga, E; Ricco, MH; Rojas, L; Romero, A; Rosa, DS; Ruiz-Peinado, R; Sang, YQ; Sauer, FG; Schmidt-Chanasit, J; Sepúlveda-García, P; Serra-Pladevall, J; Serras-Pujol, M; Shaki, F; Shao, X; Shen, L; Sheng, Z; Shi, R; Shi, YF; Shou, Q; Shu, L; Shuhua, L; Sikkema, RS; Silva-Júnior, EFD; Simon, C; Small, PK; Smith, SM; Sokas, D; Song, Y; Soudeyns, H; Souza, AG; Souza, BG; Staigyte, J; Stankeviciute, G; Stegeman, A; Stennett, MC; Stollberger, R; Sun, SK; Sun, SP; Sun-Waterhouse, D; Sundgren, NC; Sung, E; Sunseri, N; Suryadevara, SS; Tan, X; Tang, Y; Tao, F; Taparauskaite, N; Ten Bosch, Q; Titeux, H; Tobias, TJ; Tomar, S; Torres, C; Tran, DL; Tran, NT; Trudel, MJ; Tsabedze, N; Tumuluru, S; Um, MJ; Van Bui, C; Van den Brand, JMA; van den Broek, J; van der Jeugd, H; van der Klis, FRM; van der Poel, WHM; van Mastrigt, T; Varlamova, A; Venkataraman, G; Venkateswaran, ST; Venugopal, V; Vilamala, A; Vilela, GG; Visser, LG; Wagdargi, SS; Wan Ishak, WNR; Wan, S; Wang, B; Wang, DJ; Wang, H; Wang, J; Wang, JT; Wang, JY; Wang, L; Wang, LM; Wang, S; Wang, W; Wang, X; Wang, XH; Wang, Y; Wang, Z; Webster, GD; Wei, C; Wei, T; Welbourn, R; Wells, Q; Wiatrowska, B; Wong, M; Wongsomboon, V; Wu, B; Wu, Q; Wu, S; Wu, T; Wu, Y; Wu, Z; Xiang, P; Xiang, Z; Xiao, D; Xiao, L; Xiao, T; Xie, J; Xie, S; Xie, Z; Xu, B; Xu, D; Xu, H; Xue, XS; Yang, J; Yang, Y; Yao, R; Ye, L; Ye, N; Yin, X; You, L; Yu, H; Yu, J; Yun, T; Yuxuan, H; Zaaijer, HL; Zamani, E; Zang, X; Zarazaga, M; Zarembaite, G; Zaroogian, Z; Zarubin, D; Zeeshan, M; Zeng, H; Zeng, S; Zeng, XW; Zha, J; Zha, Y; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, J; Zhang, JZ; Zhang, L; Zhang, M; Zhang, R; Zhang, T; Zhang, X; Zhang, XY; Zhang, Y; Zhang, Z; Zhao, C; Zhao, P; Zhao, R; Zhao, WP; Zhao, Y; Zhao, Z; Zheng, E; Zheng, F; Zheng, H; Zhou, C; Zhou, D; Zhou, Y; Zhu, AX; Zhu, B; Zhu, J; Zhuang, H | 1 |
Cosma, I; Dvorak, J; Malich, A; Papageorgiou, I; Pfeil, A; Teichgraeber, U | 1 |
Cosma, I; Malich, A; Papageorgiou, I; Pfeil, A; Psychogios, MN; Teichgraeber, U; Tennstedt-Schenk, C; Winzler, S | 1 |
Clark, AJ; Onwuharine, EN | 1 |
Barrett, T; Buonincontri, G; Gnanapragasam, VJ; Graves, MJ; Kaggie, JD; Schulte, RF; Sushentsev, N | 1 |
Abrar, D; Albers, P; Antoch, G; Arsov, C; Boschheidgen, M; Kasprowski, L; Schimmöller, L; Ullrich, T; Wittsack, HJ | 1 |
Chiang, CS; Drake, P; Jiang, PS; Tsai, HY; Wang, FN | 1 |
Dadkhah, H; Flynn, RT; Hopfensperger, KM; Kim, Y; Wu, X | 1 |
Basilico, R; Buffone, A; Castellan, P; Caulo, M; Cianci, R; Cinalli, S; Colasante, A; d'Annibale, M; Delli Pizzi, A; Di Campli, E; Gabrielli, D; Iantorno, R; Navarra, R; Seccia, B | 1 |
Akin, O; Hötker, AM; Hricak, H; Mazaheri, Y; Shukla-Dave, A | 1 |
Antic, T; Chatterjee, A; Eggener, S; Fan, X; He, D; Karczmar, GS; Oto, A; Wang, S; Yousuf, A | 1 |
Aisa, MC; D'Andrea, A; Martorana, E; Scialpi, M | 1 |
Andriole, GL; Arett, CT; Fowler, KJ; Kim, EH; Meng, Y; Parker, AA; Shetty, AS; Vetter, JM | 1 |
Aime, S; Ciolli, L; Di Gregorio, E; Ferrauto, G; Iezzi, M; Lanzardo, S | 1 |
Akimoto, S; Hoshino, H; Makino, Y | 1 |
Aigner, F; Bektic, J; Fritz, V; Herrmann, TRW; Junker, D; Nagele, U; Rieger, M; Steinkohl, F; Tokas, T | 1 |
Aime, S; Garello, F; Lanzardo, S; Livio Longo, D; Manfredi, M; Pagoto, A; Porpiglia, F; Stefania, R; Terreno, E; Tripepi, M | 1 |
Aracil, C; Cabello, M; Estrela, P; Ge, H; I Pascu, S; Manuel Quero, J; Moschou, D; R F Rocha, P | 1 |
Hayashi, N; Koyama, D; Maeda, F; Motegi, S; Ogura, A; Tsunoda, F; Yahata, S; Yamamura, K | 1 |
Ibhagui, OY; Salarian, M; Xue, S; Yang, JJ | 1 |
Ambrosi, A; Brembilla, G; Briganti, A; Cristel, G; Damascelli, A; De Cobelli, F; Del Maschio, A; Esposito, A; Freschi, M; Montorsi, F | 1 |
Czarniecki, M | 1 |
Augusto, TM; Baratti, MO; Barbosa, GO; Bruni-Cardoso, A; Carvalho, HF; Cesar, CL; Corrêa-da-Silva, F; Damas-Souza, DM; Felisbino, SL; Ferrucci, D; Menezes, GB; Moraes-Vieira, PM; Nishan, U; Oliveira, SBP; Rosa-Ribeiro, R; Santana, JCO; Silva, JAF; Siqueira-Berti, A; Stach-Machado, DR | 1 |
Cornelis, F; Coutouly, X; Grenier, N; Hubrecht, R; Le Bras, Y; Pasticier, G; Rigou, G; Robert, G; Yacoub, M | 1 |
Betrouni, N; Colin, P; Mordon, S; Puech, P; Villers, A | 1 |
Deeg, M; Echner, H; Ernemann, U; Heckl, S; Kalbacher, H; Klose, U; Nägele, T; Schwentner, C; Sheikh, S; Sturzu, A | 1 |
Gulaka, PK; Kodibagkar, VD; Kovacs, Z; Mason, RP; Rojas-Quijano, F; Sherry, AD | 1 |
Aime, S; Arena, F; Bardini, P; Cabella, C; Colombo Serra, S; Gianolio, E; Maiocchi, A; Miragoli, L; Tedoldi, F; Uggeri, F; Valbusa, G; Visigalli, M | 1 |
Adams, QE; Breitbach, EK; Enger, SA; Flynn, RT; Kim, Y; Li, X; Rockey, WR; Wu, X; Xu, J | 1 |
Canapè, C; Catanzaro, G; Jensen, PR; Karlsson, M; Lerche, MH; Terreno, E | 1 |
Beer, AJ; Eiber, M; Kübler, H; Maurer, T; Schwaiger, M; Wester, HJ | 1 |
Wetter, A | 1 |
Bartsch, H; Bradley, WG; Choi, HW; Dale, AM; Huang, J; Kane, CJ; Karow, DS; Kuperman, JM; Liss, MA; Margolis, DJ; Marks, L; Mattrey, RF; Parsons, JK; Rakow-Penner, RA; Raman, SS; Reiter, RE; Schenker-Ahmed, N; Shabaik, A; White, NS | 1 |
Chen, YC; Chiu, HC; Hsieh, WY; Hsu, YH; Huang, WC | 1 |
Bissonnette, M; Dougherty, U; Hart, J; Karczmar, GS; Mustafi, D; Vogt, S; Ward, J | 1 |
Ardestani, MS; Mehravi, B; Mirzaei, M; Pourghasem, P; Ziaee, SA | 1 |
Hao, ZY; Liang, CZ; Lin, CM; Ma, JM; Shao, EM; Shi, HQ; Zhang, L; Zhang, YF; Zhou, J; Zhou, ZY | 1 |
Bartsch, H; Bradley, WG; Choi, HW; Dale, AM; Huang, J; Kane, CJ; Karow, DS; Kuperman, JM; Liss, MA; Margolis, DJA; Marks, L; Parsons, JK; Rakow-Penner, RA; Raman, SS; Reiter, RE; Schenker-Ahmed, N; Shabaik, A; White, NS | 1 |
Feng, J; Hekmatyar, K; Li, X; Mamouni, K; Patel, A; Pu, F; Qiao, J; Salarian, M; Tan, S; Wu, D; Xue, S; Yang, JJ; Zou, J | 1 |
Bazzocchi, M; Fongione, S; Girometti, R; Pancot, M; Pullini, S; Signor, MA; Zuiani, C | 1 |
Fukui, I; Hayashi, Y; Ikeda, H; Miyashita, K; Mizokami, A; Nagatani, H; Nakada, M; Sabit, H; Tsutsui, T | 1 |
Pu, F; Xue, S; Yang, JJ | 1 |
Barentsz, JO; Fütterer, JJ; Hambrock, T; Huisman, HJ; Hulsbergen-vandeKaa, C; van Basten, JP; van Oort, I; Witjes, JA | 1 |
Debus, J; Heilmann, M; Hennink, WE; Huber, PE; Kiessling, F; Kühnlein, R; Lammers, T; Peschke, P; Storm, G; Subr, V; Ulbrich, K | 1 |
Daducci, A; Degrassi, A; Farace, P; Fiorini, S; Marzola, P; Merigo, F; Nicolato, E; Rubello, D; Sbarbati, A; Tambalo, S | 1 |
Tweedle, MF | 1 |
Bloqueau, P; Bremon, JM; Gomez, W; Jung, L; Maniere, P; Nader, N; Palascak, P; Papavero, R; Rhomer, P; Sauvain, JL | 1 |
Bok, R; Chen, AP; Hu, S; Keshari, KR; Kurhanewicz, J; Larson, PE; Macdonald, JM; Nelson, SJ; Van Criekinge, M; Vigneron, DB; Wilson, DM | 1 |
Davidson, SR; Gertner, MR; Hlasny, E; Lawrentschuk, N; Lindner, U; Raz, O; Sussman, MS; Trachtenberg, J; Weersink, RA | 1 |
Bechor-Bar, Y; Gozin, M; Marom, H; Miller, K; Satchi-Fainaro, R; Tsarfaty, G | 1 |
Bazille, G; Lang, H; Matau, A; Pasquali, R; Roy, C | 1 |
Acher, P; Clough, RE; Dahnke, H; Keevil, SF; Schaeffter, T; Sénégas, J; Varma, G | 1 |
Huang, J; Wang, K; Wang, P; Zhang, TL; Zou, XM | 1 |
Hsieh, YK; Jiang, PS; Peng, HH; Sun, TY; Wang, CF; Yang, BS | 1 |
Cai, Q; Chakravarty, S; Goswami, LN; Hawthorne, MF; Jalisatgi, SS; Ma, L | 1 |
Enger, SA; Fisher, DR; Flynn, RT | 1 |
Cai, Q; Goswami, LN; Hawthorne, MF; Jalisatgi, SS; Ma, L; Sarma, SJ | 1 |
Bruneteau, G; Clément, O; Cuénod, CA; Frija, G; Frouin, F; Kahn, E; Pradel, C; Siauve, N | 1 |
Braun, K; Debus, J; Heckl, S; Jenne, J; Pipkorn, R; Rastert, R; Spring, H; von der Lieth, CW; Waldeck, W | 1 |
Bock, M; Delorme, S; Fink, C; Fusenig, NE; Grobholz, R; Kiessling, F; Lichy, MP; Misselwitz, B; Peschke, P | 1 |
Bostwick, DG; Collins, JM; Corica, A; Huidobro, C; Larson, BT; Vallejo, S | 1 |
Donnelly, BJ; Donnelly, SE; Raber, EL; Saliken, JC; Vellet, AD | 1 |
Di Trapani, G; Falcioni, M; Piccirillo, E; Romano, G; Russo, A | 1 |
Berean, KW; Chang, SD; Chen, H; Goldenberg, SL; Jones, EC; Kozlowski, P | 1 |
Cornud, F; Peyromaure, M; Rebillard, X; Soulié, M; Villers, A | 1 |
Younes, P | 1 |
Eden, CG; Hatrick, A; Richards, AJ | 1 |
Bonanno, E; Carlani, M; Finazzi Agrò, E; Mancino, S; Simonetti, G | 1 |
Harris, RD; Heaney, JA; Schned, AR | 1 |
Chanson, P; Schaison, G | 1 |
Belin, X; Chrétien, Y; Cornud, F; Corréas, JM; Dufour, B; Fromont, G; Hélénon, O; Melki, P; Moreau, JF | 1 |
Chrousos, GC; Kattah, JC; Kolsky, M; Manz, H; Roberts, J; Zimmerman, L | 1 |
Schnall, MD; Siegelman, ES | 1 |
Böni, RA; Debatin, JF; Jochum, W; Krestin, GP; Romanowski, B; Sulser, T | 1 |
Barentsz, JO; de la Rosette, JJ; Jager, GJ; Oosterhof, GO; Ruijs, SH; Ruijter, ET; Thornbury, JR; van de Kaa, CA | 1 |
Ali-Ridha, NH; Donnelly, B; McLaughlin, RF; Raber, E; Saliken, J; Vellet, AD; Wiseman, D | 1 |
Ishizaka, H; Suzuki, K; Totsuka, Y; Yamanaka, H | 1 |
Audin, J; Cantereau, A; Dufy, B; Georgescauld, D; Perret, S | 1 |
Barentsz, JO; de LaRosette, J; Engelbrecht, M; Heerschap, A; Huisman, HJ; Jager, GJ; van Der Sanden, BP; Witjes, JA | 1 |
Djamgoz, MB; Fraser, SP; Verrall, J | 1 |
Brasch, RC; Gossman, A; Helbich, TH; Mareski, PA; Mühler, M; Radüchel, B; Roberts, TP; Shames, DM; Turetschek, K | 1 |
Heerschap, A; Joosten, FB; Kaanders, JH; Rijpkema, M; van der Kogel, AJ | 1 |
Cochran, ST; Mesa, A; Norman, A; Solberg, TD | 1 |
Gevenois, PA; Salmon, I; Simon, J; Sintzoff, SA; Stallenberg, B; Struyven, J; Van Regemorter, G | 1 |
4 review(s) available for gadolinium and Prostatic Neoplasms
Article | Year |
---|---|
[Place of contrast imaging in prostate cancer detection].
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Prostatic Neoplasms; Ultrasonography | 2006 |
[MRI of prostate cancer].
Topics: Biopsy; Contrast Media; Dextrans; Diagnosis, Differential; Ferrosoferric Oxide; Gadolinium; Humans; Iron; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetite Nanoparticles; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Oxides; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Prostatitis; Seminal Vesicles; Ultrasonography | 2007 |
Contrast-enhanced MR imaging of the bladder and prostate.
Topics: Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Prostate; Prostatic Diseases; Prostatic Neoplasms; Urinary Bladder; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1996 |
Fast dynamic gadolinium-enhanced MR imaging of urinary bladder and prostate cancer.
Topics: Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Neoplasm Staging; Prostatic Neoplasms; Signal Processing, Computer-Assisted; Urinary Bladder; Urinary Bladder Neoplasms | 1999 |
2 trial(s) available for gadolinium and Prostatic Neoplasms
Article | Year |
---|---|
Real-time contrast-enhanced transrectal US-guided prostate biopsy: diagnostic accuracy in men with previously negative biopsy results and positive MR imaging findings.
Topics: Adult; Aged; Computer Systems; Contrast Media; Endoscopic Ultrasound-Guided Fine Needle Aspiration; False Negative Reactions; False Positive Reactions; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity | 2013 |
Gadolinium-DOTA enhanced MR imaging of prostatic lesions. Preliminary results on 14 cases.
Topics: Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatitis | 1992 |
80 other study(ies) available for gadolinium and Prostatic Neoplasms
Article | Year |
---|---|
Using micro-synchrotron radiation x-ray fluorescence (µ-SRXRF) for trace metal imaging in the development of MRI contrast agents for prostate cancer imaging.
Topics: Animals; Contrast Media; Fluorescence; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Mice; Prostatic Neoplasms; Spectrometry, X-Ray Emission; Synchrotrons; Trace Elements; X-Rays; Zinc | 2022 |
Quantitative Evaluation of late Gadolinium Enhancement to the Differential Diagnosis of Prostate Cancer and Prostatitis in mpMRI.
Topics: Contrast Media; Diagnosis, Differential; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiparametric Magnetic Resonance Imaging; Prostatic Neoplasms; Prostatitis; Retrospective Studies | 2023 |
Effect of 12-week of aerobic exercise on hormones and lipid profile status in adolescent girls with polycystic ovary syndrome: A study during COVID-19.
Topics: Acrylamides; Actins; Adult; African People; Air Pollutants; Alanine Transaminase; Androgens; Animals; Anti-Bacterial Agents; Antibodies, Bispecific; Antiviral Agents; Arteries; Bioelectric Energy Sources; Bioreactors; Brain; Carbon Dioxide; Carbon Tetrachloride; Cardiomyopathy, Dilated; Cerebral Cortex; Cerebrovascular Circulation; Charcoal; Chemical and Drug Induced Liver Injury; Chikungunya Fever; Chikungunya virus; Chitosan; Chlorocebus aethiops; Claudins; Contrast Media; Cynodon; Cytokines; Desmin; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Ecosystem; Elasticity Imaging Techniques; Escherichia coli; Fatty Acids, Volatile; Female; Fermentation; Filtration; Food; Gadolinium; Galactose; Gastrointestinal Microbiome; Gene Expression; Gene Expression Regulation, Leukemic; Gracilaria; Heart Failure; HeLa Cells; Hematopoietic Stem Cells; Hepatic Stellate Cells; Hepatitis B e Antigens; Hepatitis B, Chronic; Hepatocytes; HIV; HIV Infections; Humans; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydroxy Acids; Hydroxyl Radical; Imaging, Three-Dimensional; Immunity; Inflammation; Interferon-gamma; Interleukin-17; Interleukin-33; Interleukin-4; Keratin-18; Kinetics; Leukemia, Myeloid, Acute; Leukocytes, Mononuclear; Lipidomics; Lipids; Liver; Liver Cirrhosis; Lymphocyte Activation; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microalgae; Middle Aged; Mutation; Nanoparticles; Nitrogen; Nuclear Proteins; Oxidation-Reduction; Particulate Matter; Phylogeny; Phytoplankton; Placenta; Polysaccharides; Polystyrenes; Polyvinyl Alcohol; Predictive Value of Tests; Pregnancy; Prognosis; Programmed Cell Death 1 Receptor; Prospective Studies; Prostate; Prostatic Neoplasms; Rain; Receptors, Immunologic; Recombinant Proteins; Refuse Disposal; Reproducibility of Results; Restaurants; Retrospective Studies; Reverse Transcriptase Inhibitors; Sand; Seawater; Sheep; Sheep, Domestic; Sodium Hydroxide; Spin Labels; Stomach Neoplasms; Stroke Volume; Sulfates; Tensile Strength; Th1 Cells; Th17 Cells; Th2 Cells; Transcriptome; Tumor Microenvironment; Ultraviolet Rays; Ventricular Function, Left; Vero Cells; Virus Replication; Waste Disposal, Fluid; Wastewater; Water; Water Pollutants, Chemical; Water Purification; Water Supply; Wetlands; Xylitol; Xylose | 2023 |
Whole-body MRI: a powerful alternative to bone scan for bone marrow staging without radiation and gadolinium enhancer.
Topics: Bone Neoplasms; Breast Neoplasms; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Incidental Findings; Lung Neoplasms; Magnetic Resonance Imaging; Male; Organometallic Compounds; Predictive Value of Tests; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Whole Body Imaging | 2020 |
The role of gadolinium in magnetic resonance imaging for early prostate cancer diagnosis: A diagnostic accuracy study.
Topics: Aged; Area Under Curve; Contrast Media; Early Detection of Cancer; Gadolinium; Humans; Image-Guided Biopsy; Male; Middle Aged; Multiparametric Magnetic Resonance Imaging; Prostate; Prostatic Neoplasms; ROC Curve | 2019 |
Comparison of double inversion recovery magnetic resonance imaging (DIR-MRI) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in detection of prostate cancer: A pilot study.
Topics: Aged; Aged, 80 and over; Contrast Media; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Prostate; Prostatic Neoplasms | 2020 |
The effect of gadolinium-based contrast agent administration on magnetic resonance fingerprinting-based T
Topics: Aged; Contrast Media; Gadolinium; Humans; Linear Models; Magnetic Resonance Imaging; Male; Prostate; Prostatic Neoplasms | 2020 |
Arterial spin labelling as a gadolinium-free alternative in the detection of prostate cancer.
Topics: Cohort Studies; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Prostatic Neoplasms; Spin Labels | 2021 |
Gadolinium-doped iron oxide nanoparticles induced magnetic field hyperthermia combined with radiotherapy increases tumour response by vascular disruption and improved oxygenation.
Topics: Animals; Cell Line, Tumor; Combined Modality Therapy; Gadolinium; Hyperthermia, Induced; Hypoxia; Magnetic Fields; Magnetite Nanoparticles; Male; Mice, Inbred C57BL; Prostatic Neoplasms; Tumor Burden | 2017 |
Multisource Rotating Shield Brachytherapy Apparatus for Prostate Cancer.
Topics: Brachytherapy; Equipment Design; Feasibility Studies; Gadolinium; Humans; Male; Needles; Organ Sparing Treatments; Organs at Risk; Prostatic Neoplasms; Radiation Protection; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rotation; Time Factors; Uncertainty; Urethra | 2017 |
Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
Topics: Aged; Biopsy; Contrast Media; Diffusion Magnetic Resonance Imaging; Digital Rectal Examination; Epidemiologic Methods; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prostate; Prostatic Neoplasms | 2018 |
Effect of intravascular contrast agent on diffusion and perfusion fraction coefficients in the peripheral zone and prostate cancer.
Topics: Aged; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium; Humans; Image Enhancement; Male; Middle Aged; Prostate; Prostatic Neoplasms; Retrospective Studies; Signal-To-Noise Ratio | 2018 |
Feasibility of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using Low-Dose Gadolinium: Comparative Performance With Standard Dose in Prostate Cancer Diagnosis.
Topics: Adult; Aged; Contrast Media; Feasibility Studies; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Prospective Studies; Prostate; Prostatic Neoplasms; ROC Curve | 2018 |
Simplified Prostate Imaging Reporting and Data System for Biparametric Prostate MRI: A Proposal.
Topics: Adult; Aged; Contrast Media; Gadolinium; Humans; Image-Guided Biopsy; Magnetic Resonance Imaging; Male; Middle Aged; Prostatic Neoplasms; Radiology Information Systems | 2018 |
Improved Detection of Clinically Significant Prostate Cancer With Software-assisted Systematic Biopsy Using MR/US Fusion in Patients With Negative Prostate MRI.
Topics: Biopsy, Needle; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium; Humans; Image-Guided Biopsy; Male; Middle Aged; Prostate; Prostatic Neoplasms; Retrospective Studies; Software; Ultrasonography | 2018 |
Generation of multiparametric MRI maps by using Gd-labelled- RBCs reveals phenotypes and stages of murine prostate cancer.
Topics: Adenocarcinoma; Animals; Contrast Media; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Erythrocyte Count; Erythrocytes; Gadolinium; Heterocyclic Compounds; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Staging; Organometallic Compounds; Organophosphorus Compounds; Prostate; Prostatic Neoplasms | 2018 |
[Influence of Different Contrast Agent Concentrations and Injection Protocols on Dynamic Contrast Enhanced MRI of Prostate: Equimolar Comparison of 1.0M Gadobutrol and 0.5M Gadolinium Chelates].
Topics: Contrast Media; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Organometallic Compounds; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity | 2018 |
Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?
Topics: Aged; Contrast Media; Gadolinium; Humans; Image-Guided Biopsy; Magnetic Resonance Imaging; Male; Middle Aged; Multiparametric Magnetic Resonance Imaging; Neoplasm Grading; Prostate; Prostatectomy; Prostatic Neoplasms; Retrospective Studies | 2019 |
An efficient MRI agent targeting extracellular markers in prostate adenocarcinoma.
Topics: Acetates; Adenocarcinoma; Animals; Azepines; Biomarkers, Tumor; Cell Line, Tumor; Contrast Media; Fibrin; Fibronectins; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Neoplasm Transplantation; Peptides; Prostatic Neoplasms; Protein Binding; Spectrometry, Mass, Electrospray Ionization | 2019 |
Extracellular Electrophysiology in the Prostate Cancer Cell Model PC-3.
Topics: Calcium Channel Blockers; Electricity; Electrodes; Electrophysiological Phenomena; Extracellular Space; Gadolinium; Humans; Ion Channel Gating; Male; Models, Biological; PC-3 Cells; Prostatic Neoplasms | 2019 |
Slow component apparent diffusion coefficient for prostate cancer: Comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging.
Topics: Aged; Aged, 80 and over; Biopsy; Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium; Humans; Male; Middle Aged; Motion; Prostate; Prostatic Neoplasms; Reproducibility of Results | 2019 |
Designing Calcium-Binding Proteins for Molecular MR Imaging.
Topics: Animals; Calcium; Cell Line, Tumor; Contrast Media; Early Detection of Cancer; Gadolinium; Humans; Kallikreins; Magnetic Resonance Imaging; Male; Mice; Models, Molecular; Molecular Conformation; Molecular Imaging; Neoplasm Transplantation; Parvalbumins; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Engineering | 2019 |
MpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer?
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Gadolinium; Humans; Image Enhancement; Male; Middle Aged; Multiparametric Magnetic Resonance Imaging; Prostate; Prostatic Neoplasms; Reproducibility of Results | 2019 |
Commentary on: mpMRI of the prostate: is there a role for semi-quantitative analysis of DCE-MRI and late gadolinium enhancement in the characterisation of prostate cancer?
Topics: Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multiparametric Magnetic Resonance Imaging; Prostatic Neoplasms | 2019 |
Castration-induced prostate epithelial cell apoptosis results from targeted oxidative stress attack of M1
Topics: Androgen Antagonists; Androgens; Animals; Apoptosis; Cell Line; Epithelial Cells; Gadolinium; Macrophages; Male; Mice; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidative Stress; Prostate; Prostatic Neoplasms; Rats; Rats, Wistar; RAW 264.7 Cells; Trans-Activators; Transcription Factors | 2019 |
An image guided treatment platform for prostate cancer photodynamic therapy.
Topics: Bacteriochlorophylls; Calibration; Equipment Design; Gadolinium; Humans; Image Processing, Computer-Assisted; Imagery, Psychotherapy; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Photochemotherapy; Predictive Value of Tests; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Reproducibility of Results; Treatment Outcome; Ultrasonography | 2013 |
The gastrin/cholecystokinin-B receptor on prostate cells--a novel target for bifunctional prostate cancer imaging.
Topics: Animals; Cell Line, Tumor; Contrast Media; Fluorescent Dyes; Gadolinium; Gastrins; Heterocyclic Compounds, 1-Ring; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Oligopeptides; Prostate; Prostatic Neoplasms; Receptor, Cholecystokinin B; Rhodamines | 2014 |
GdDO3NI, a nitroimidazole-based T1 MRI contrast agent for imaging tumor hypoxia in vivo.
Topics: Animals; Biological Transport; Cell Hypoxia; Contrast Media; Gadolinium; Magnetic Resonance Imaging; Male; Nitroimidazoles; Organometallic Compounds; Prostatic Neoplasms; Rats | 2014 |
B25716/1: a novel albumin-binding Gd-AAZTA MRI contrast agent with improved properties in tumor imaging.
Topics: Animals; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Mice; Prostatic Neoplasms | 2014 |
Interstitial rotating shield brachytherapy for prostate cancer.
Topics: Brachytherapy; Catheters; Equipment Design; Gadolinium; Humans; Iridium Radioisotopes; Male; Monte Carlo Method; Needles; Nickel; Platinum Compounds; Prostatic Neoplasms; Radiation Protection; Radioisotopes; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rectum; Time Factors; Titanium; Urethra; Urinary Bladder | 2014 |
Probing treatment response of glutaminolytic prostate cancer cells to natural drugs with hyperpolarized [5-(13) C]glutamine.
Topics: Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Carbon Isotopes; Cells, Cultured; Chromatography, High Pressure Liquid; Contrast Media; Enzyme-Linked Immunosorbent Assay; Gadolinium; Glutamine; Heterocyclic Compounds; Humans; In Vitro Techniques; Isothiocyanates; Magnetic Resonance Spectroscopy; Male; Organometallic Compounds; Phenotype; Prostatic Neoplasms; Resveratrol; Stilbenes; Sulfoxides | 2015 |
Positron emission tomography/magnetic resonance imaging with 68Gallium-labeled ligand of prostate-specific membrane antigen: promising novel option in prostate cancer imaging?
Topics: Aged; Antigens, Surface; Diagnosis, Differential; Diagnostic Imaging; Gadolinium; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prostatic Neoplasms | 2014 |
Editorial Comment to Positron emission tomography/magnetic resonance imaging with 68Gallium-labeled ligand of prostate-specific membrane antigen: promising novel option in prostate cancer imaging?
Topics: Antigens, Surface; Diagnostic Imaging; Gadolinium; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prostatic Neoplasms | 2014 |
Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension.
Topics: Aged; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiography | 2015 |
Development of a diagnostic polymersome system for potential imaging delivery.
Topics: Acrylic Resins; Animals; Biological Transport; Carbocyanines; Cell Survival; Contrast Media; Diglycerides; Drug Delivery Systems; Fluorescent Dyes; Gadolinium; HeLa Cells; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Molecular Imaging; Neoplasm Transplantation; Polymerization; Prostatic Neoplasms | 2015 |
X-ray fluorescence microscopy demonstrates preferential accumulation of a vanadium-based magnetic resonance imaging contrast agent in murine colonic tumors.
Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Contrast Media; Electron Probe Microanalysis; Female; Gadolinium; Glycolysis; Humans; Magnetic Resonance Imaging; Male; Mice; Microscopy, Fluorescence; Neoplasm Transplantation; Positron-Emission Tomography; Prostatic Neoplasms; Vanadium | 2015 |
In Vitro Evaluation of Gd(3+)-Anionic Linear Globular Dendrimer-Monoclonal Antibody: Potential Magnetic Resonance Imaging Contrast Agents for Prostate Cancer Cell Imaging.
Topics: Antibodies, Monoclonal; Cell Line, Tumor; Contrast Media; Gadolinium; Humans; Immunoconjugates; In Vitro Techniques; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mucin-1; Prostatic Neoplasms | 2015 |
Inhibition of Transient Receptor Potential Melastain 7 Enhances Apoptosis Induced by TRAIL in PC-3 cells.
Topics: Apoptosis; Boron Compounds; Cell Line, Tumor; Gadolinium; Humans; Male; Phosphatidylinositol 3-Kinases; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; RNA, Small Interfering; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; TRPM Cation Channels; Up-Regulation | 2015 |
Prostate diffusion imaging with distortion correction.
Topics: Contrast Media; Diffusion Magnetic Resonance Imaging; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Prostate; Prostatic Neoplasms | 2015 |
Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI.
Topics: Animals; Antigens, Surface; Cell Line, Tumor; Contrast Media; Gadolinium; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Molecular Imaging; Neoplasms, Experimental; Prostatic Neoplasms | 2016 |
Impact of multiparametric magnetic resonance imaging on risk group assessment of patients with prostate cancer addressed to external beam radiation therapy.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Contrast Media; Diffusion Magnetic Resonance Imaging; Digital Rectal Examination; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Male; Meglumine; Middle Aged; Neoplasm Grading; Neoplasm Staging; Organometallic Compounds; Patient Care Planning; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment | 2016 |
Acute Progression of Recurrent Meningioma during Luteinizing Hormone-Releasing Hormone Agonist Treatment for Prostate Cancer.
Topics: Aged; Antineoplastic Agents, Hormonal; Cognition Disorders; Disease Progression; Gadolinium; Gait Disorders, Neurologic; Humans; Ki-67 Antigen; Leuprolide; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Neoplasm Recurrence, Local; Neoplasm, Residual; Prostatic Neoplasms; Radiosurgery | 2016 |
ProCA1.GRPR: a new imaging agent in cancer detection.
Topics: Animals; Biomarkers, Tumor; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Mice; Neoplasms; Prostatic Neoplasms; Receptors, Bombesin | 2016 |
Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.
Topics: Aged; Biopsy; Feasibility Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms | 2008 |
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy.
Topics: Acrylamides; Animals; Antimetabolites, Antineoplastic; Combined Modality Therapy; Deoxycytidine; Diagnostic Imaging; Doxorubicin; Drug Delivery Systems; Drug Resistance, Neoplasm; Gadolinium; Gemcitabine; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Nanomedicine; Prostatic Neoplasms; Radiation Tolerance; Rats; Ribonucleotide Reductases; Tissue Distribution | 2008 |
DCE-MRI using small-molecular and albumin-binding contrast agents in experimental carcinomas with different stromal content.
Topics: Animals; Cell Line, Tumor; Contrast Media; Gadolinium; Gadolinium DTPA; Image Enhancement; Image Interpretation, Computer-Assisted; Immunoenzyme Techniques; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Neoplasms, Experimental; Organometallic Compounds; Pancreatic Neoplasms; Prostatic Neoplasms | 2011 |
Peptide-targeted diagnostics and radiotherapeutics.
Topics: Amino Acid Sequence; Angiogenesis Inhibitors; Animals; Cell Line; ErbB Receptors; Gadolinium; Humans; Lutetium; Male; Molecular Sequence Data; Neoplasms; Oligopeptides; Peptides; Positron-Emission Tomography; Prostatic Neoplasms; Protein Binding; Radiopharmaceuticals; Rats; Receptors, G-Protein-Coupled; Tuftsin | 2009 |
[MRI and prostatic cancer: measurements of kinetic perfusion parameters of gadolinium with a computerized-aided diagnostic tool (CAD)].
Topics: Aged; Automation; Biopsy; Colorimetry; Gadolinium; Humans; Image Processing, Computer-Assisted; Kinetics; Magnetic Resonance Imaging; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Radiography; Risk Assessment; Sensitivity and Specificity | 2010 |
Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo.
Topics: Animals; Biomarkers, Tumor; Enzymes; Fumarates; Gadolinium; Hydrogen-Ion Concentration; Indicators and Reagents; Injections, Intravenous; Isotope Labeling; Magnetic Resonance Spectroscopy; Male; Mice; Necrosis; Neoplasm Transplantation; Prostatic Neoplasms; Pyruvic Acid; Sodium Bicarbonate; Solubility; Urea | 2010 |
Construction and evaluation of an anatomically correct multi-image modality compatible phantom for prostate cancer focal ablation.
Topics: Equipment Design; Gadolinium; Gels; Humans; Magnetic Resonance Imaging, Interventional; Male; Models, Anatomic; Phantoms, Imaging; Prostate; Prostatic Neoplasms; Radiography, Interventional; Rectum; Ultrasonography, Interventional; Urethra | 2010 |
Toward development of targeted nonsteroidal antiandrogen-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-gadolinium complex for prostate cancer diagnostics.
Topics: Androgen Antagonists; Anilides; Animals; Coordination Complexes; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Prostatic Neoplasms; Receptors, Androgen; Stereoisomerism; Structure-Activity Relationship | 2010 |
[The role of diffusion 3-Tesla MRI in detecting prostate cancer before needle biopsy: multiparametric study of 111 patients].
Topics: Aged; Biomarkers, Tumor; Biopsy, Needle; Cohort Studies; Contrast Media; Diffusion Magnetic Resonance Imaging; Endosonography; Gadolinium; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Ultrasonography, Interventional | 2010 |
Positive visualization of implanted devices with susceptibility gradient mapping using the original resolution.
Topics: Alloys; Aortic Aneurysm, Thoracic; Aortic Dissection; Brachytherapy; Computer Simulation; Gadolinium; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Models, Theoretical; Organometallic Compounds; Phantoms, Imaging; Prostatic Neoplasms; Software; Stents | 2011 |
Gadolinium inhibits prostate cancer PC3 cell migration and suppresses osteoclast differentiation in vitro.
Topics: Animals; Apoptosis; Blotting, Western; Calcium; Cell Adhesion; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Survival; Gadolinium; Humans; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Microscopy, Confocal; Osteoclasts; Phosphorylation; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Wound Healing | 2011 |
Using laser ablation/inductively coupled plasma mass spectrometry to bioimage multiple elements in mouse tumors after hyperthermia.
Topics: Animals; Cell Line, Tumor; Elements; Ferric Compounds; Gadolinium; Hot Temperature; Humans; Laser Therapy; Male; Mass Spectrometry; Metal Nanoparticles; Metals, Heavy; Mice; Mice, Inbred C57BL; Neoplasms; Prostatic Neoplasms; Radiography; Staining and Labeling | 2011 |
Discrete nanomolecular polyhedral borane scaffold supporting multiple gadolinium(III) complexes as a high performance MRI contrast agent.
Topics: Animals; Boranes; Contrast Media; Female; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred Strains; Mice, SCID; Molecular Structure; Nanostructures; Neoplasms, Experimental; Organometallic Compounds; Polymers; Prostatic Neoplasms | 2013 |
Gadolinium-153 as a brachytherapy isotope.
Topics: Anisotropy; Brachytherapy; Equipment Design; Gadolinium; Humans; Iridium Radioisotopes; Male; Monte Carlo Method; Photons; Prostatic Neoplasms; Radiation Protection; Radioisotopes; Radiotherapy Dosage; Scattering, Radiation | 2013 |
cRGD peptide-conjugated icosahedral closo-B12(2-) core carrying multiple Gd3+-DOTA chelates for α(v)β3 integrin-targeted tumor imaging (MRI).
Topics: Animals; Cell Line, Tumor; Chelating Agents; Contrast Media; Gadolinium; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Magnetic Resonance Imaging; Male; Mice; Mice, SCID; Molecular Structure; Neoplasms, Experimental; Peptides, Cyclic; Prostatic Neoplasms; Vitamin B 12 | 2013 |
Assessing perfusion and capillary permeability changes induced by a VEGF inhibitor in human tumor xenografts using macromolecular MR imaging contrast media.
Topics: Animals; Capillary Permeability; Contrast Media; Endothelial Growth Factors; Gadolinium; Heterocyclic Compounds; Intercellular Signaling Peptides and Proteins; Lymphokines; Macromolecular Substances; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; Organometallic Compounds; Perfusion; Prostatic Neoplasms; Quinazolines; Transplantation, Heterologous; Triazoles; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
CNN-Gd(3+) enables cell nucleus molecular imaging of prostate cancer cells: the last 600 nm.
Topics: Amino Acid Sequence; Antennapedia Homeodomain Protein; Cell Nucleus; Contrast Media; Gadolinium; Homeodomain Proteins; Humans; Magnetic Resonance Imaging; Male; Models, Molecular; Molecular Sequence Data; Nuclear Proteins; Organometallic Compounds; Peptide Fragments; Prostatic Neoplasms; Protein Transport; Sequence Homology, Amino Acid; Transcription Factors | 2002 |
High-resolution three-dimensional MR angiography of rodent tumors: morphologic characterization of intratumoral vasculature.
Topics: Animals; Contrast Media; Gadolinium; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Angiography; Male; Mice; Mice, Nude; Neovascularization, Pathologic; Prostatic Neoplasms; Rats; Skin Neoplasms | 2003 |
Gadolinium-enhanced MRI in the evaluation of minimally invasive treatments of the prostate: correlation with histopathologic findings.
Topics: Adenocarcinoma; Contrast Media; Cryotherapy; Gadolinium; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Male; Minimally Invasive Surgical Procedures; Necrosis; Prostatectomy; Prostatic Neoplasms | 2003 |
Prostate cancer: gadolinium-enhanced MR imaging at 3 weeks compared with needle biopsy at 6 months after cryoablation.
Topics: Aged; Biopsy, Needle; Cryosurgery; Follow-Up Studies; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; Prostatic Neoplasms; Time Factors | 2004 |
Internal auditory canal metastasis.
Topics: Aged; Biopsy; Carcinoma, Squamous Cell; Cerebellopontine Angle; Cranial Nerve Neoplasms; Diagnosis, Differential; Ear Neoplasms; Facial Nerve; Female; Follow-Up Studies; Gadolinium; Hearing Loss, Sensorineural; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Prostatic Neoplasms; Time Factors; Uterine Neoplasms; Vestibulocochlear Nerve; Vestibulocochlear Nerve Diseases | 2004 |
Combined diffusion-weighted and dynamic contrast-enhanced MRI for prostate cancer diagnosis--correlation with biopsy and histopathology.
Topics: Aged; Biopsy; Carcinoma; Contrast Media; Diffusion; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Sensitivity and Specificity; Time Factors | 2006 |
Large pelvic arteriovenous malformation complicating laparoscopic radical prostatectomy.
Topics: Arteriovenous Malformations; Contrast Media; Embolization, Therapeutic; Gadolinium; Humans; Intraoperative Care; Laparoscopy; Magnetic Resonance Angiography; Male; Middle Aged; Pelvis; Prostatectomy; Prostatic Neoplasms; Treatment Outcome | 2008 |
Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
Topics: Aged; Choline; Citric Acid; Contrast Media; Creatine; Gadolinium; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Meglumine; Middle Aged; Organometallic Compounds; Prostate; Prostatic Neoplasms; Whole Body Imaging | 2008 |
Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve.
Topics: Case-Control Studies; Contrast Media; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Neoplasm Staging; Predictive Value of Tests; Prostate; Prostatic Neoplasms; Seminal Vesicles; Sensitivity and Specificity | 1995 |
Pituitary apoplexy caused by GnRH-agonist treatment revealing gonadotroph adenoma.
Topics: Adenoma; Aged; Contrast Media; Cyproterone Acetate; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Pituitary Apoplexy; Pituitary Neoplasms; Prostatic Neoplasms; Triptorelin Pamoate | 1995 |
[MRI in cancer of the prostate with T1-weighted sequences using fat suppression and injection of gadolinium].
Topics: Aged; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Prostate; Prostatic Neoplasms; Seminal Vesicles; Sensitivity and Specificity | 1994 |
Metastatic prostate cancer to the optic canal.
Topics: Aged; Aged, 80 and over; Blindness; Carcinoma; Combined Modality Therapy; Cranial Nerve Neoplasms; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Orbit; Papilledema; Prostatic Neoplasms | 1993 |
Laser ablation-induced changes in the prostate: findings at endorectal MR imaging with histologic correlation.
Topics: Aged; Carcinoma; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Laser Therapy; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Prostate; Prostatectomy; Prostatic Neoplasms | 1997 |
Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results.
Topics: Aged; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Observer Variation; Organometallic Compounds; Pentetic Acid; Prostate; Prostatectomy; Prostatic Hyperplasia; Prostatic Neoplasms; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method; Subtraction Technique | 1997 |
Prostatic cryosurgery: use of MR imaging in evaluation of success and technical modifications.
Topics: Adenocarcinoma; Aged; Biopsy; Contrast Media; Cryosurgery; Evaluation Studies as Topic; Follow-Up Studies; Gadolinium; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Necrosis; Neoplasm Staging; Neoplasm, Residual; Postoperative Care; Preoperative Care; Prostate; Prostatectomy; Prostatic Neoplasms; Rectum; Treatment Outcome; Ultrasonography; Urinary Bladder | 1997 |
Usefulness of preoperative MRI diagnosis in prostatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Metastasis; Predictive Value of Tests; Prostatic Neoplasms; Sensitivity and Specificity | 1997 |
Interplay between Ca2+ release and Ca2+ influx underlies localized hyperpolarization-induced [Ca2+]i waves in prostatic cells.
Topics: Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Polarity; Electric Stimulation; Enzyme Inhibitors; Fura-2; Gadolinium; Humans; Lanthanum; Male; Manganese; Microscopy, Confocal; Nimodipine; Prostatic Neoplasms; Ryanodine; Thapsigargin; Tumor Cells, Cultured | 1999 |
Effects of gadolinium ions upon rat prostatic cancer cell lines of markedly different metastatic potential.
Topics: Animals; Biomechanical Phenomena; Carcinoma; Cell Division; Cell Movement; Drug Screening Assays, Antitumor; Gadolinium; Ion Channels; Lung Neoplasms; Lymphatic Metastasis; Male; Prostatic Neoplasms; Rats; Tumor Cells, Cultured | 1999 |
A new polysaccharide macromolecular contrast agent for MR imaging: biodistribution and imaging characteristics.
Topics: Analysis of Variance; Animals; Contrast Media; Disease Models, Animal; Female; Gadolinium; Hydroxyethyl Starch Derivatives; Image Enhancement; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Male; Organometallic Compounds; Prostate; Prostatic Neoplasms; Rats; Sensitivity and Specificity; Software; Tissue Distribution | 2000 |
Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors.
Topics: Algorithms; Brain Neoplasms; Contrast Media; Gadolinium; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Neoplasms; Prostatic Neoplasms; Reproducibility of Results; Tissue Distribution | 2001 |
Contrast-enhanced brachytherapy for prostate cancer.
Topics: Animals; Brachytherapy; Contrast Media; Gadolinium; Male; Mice; Monte Carlo Method; Prostatic Neoplasms; Silver | 2002 |